Article info
Myositis
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis
- Correspondence to Dr Naoko Okiyama, Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan; naoko.okiyama{at}md.tsukuba.ac.jp
Citation
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis
Publication history
- Received July 21, 2020
- Revised March 9, 2021
- Accepted March 21, 2021
- First published April 2, 2021.
Online issue publication
April 04, 2023
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.